Hence, drugs affecting nitric oxide homeostasis and production (NO-based drugs), that showed promising results for metastatic melanoma patients, might extend the panel of treatment options for non-responders to current therapies and relapse cases [22]
Peeters F, Cassiman C, Van Keer K, Levtchenko E, Veys K, Casteels I (2019) Ophthalmic outcome in a Belgian cohort of cystinosis patients treated with a compounded preparation of cysteamine eye drops: retrospective analysis
Furthermore, novel formulations of intra-articular therapeutics, such as glucosinolates and enhanced hyaluronic acid, are being explored for their potential to provide both analgesic and structural benefits (Gambari et al., 2025)
Update on pancreatic intraepithelial neoplasia